NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 89 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,000 | -84.6% | 5,000 | -81.8% | 0.00% | -83.3% |
| Q4 2014 | $52,000 | +44.4% | 27,500 | 0.0% | 0.02% | +9.1% |
| Q3 2014 | $36,000 | -20.0% | 27,500 | -9.8% | 0.02% | -56.9% |
| Q2 2014 | $45,000 | -19.6% | 30,500 | 0.0% | 0.05% | +8.5% |
| Q1 2014 | $56,000 | -11.1% | 30,500 | 0.0% | 0.05% | -11.3% |
| Q4 2013 | $63,000 | -22.2% | 30,500 | 0.0% | 0.05% | -32.9% |
| Q3 2013 | $81,000 | 0.0% | 30,500 | 0.0% | 0.08% | -33.6% |
| Q2 2013 | $81,000 | – | 30,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |